ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · IEX Real-Time Price · USD

18.77

-0.43 (-2.24%)

At close: Jul 19, 2024, 4:30 PM

18.90

+0.13 (0.69%)

Pre-market: Jul 22, 2024, 8:00 AM EDT

ArriVent BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Market Capitalization	629	-	-
Enterprise Value	312	-150	-163
PB Ratio	1.98	-	-
EV/EBITDA Ratio	-	2.16	4.42
EV/EBIT Ratio	-	2.16	4.42
EV/FCF Ratio	-	2.69	3.74
Debt / Equity Ratio	0.00	0.00	0.00
Debt / EBITDA Ratio	-	0.00	0.00
Debt / FCF Ratio	-	-0.01	0.00
Quick Ratio	31.81	12.94	19.54
Current Ratio	32.82	13.76	21.85
Return on Equity (ROE)	-	58.20%	168.20%
Return on Assets (ROA)	-	-40.10%	-32.70%
Return on Capital (ROIC)	-	48.79%	43.43%
Earnings Yield	-11.86%	-	-
Buyback Yield / Dilution	-1861.24%	-67.64%	-
Total Shareholder Return	-1861.24%	-67.64%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).